Genome-Based Recombinant Protein Production via Chromosomal Integration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Plasmid-based expression systems for recombinant protein production in bacterial hosts, such as E. coli, face limitations due to high metabolic burden, segregational and structural instability, and uncontrollable gene dosage, leading to low yield and quality of recombinant proteins.
Innovation Solution
A plasmid-free method involving genome-based expression systems where a DNA construct with a gene of interest is integrated into the bacterial genome using an inducible promoter like P BAD , allowing for controlled expression and integration at specific loci, enabling stable and efficient production of recombinant proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If plasmid-based expression systems are used to achieve high gene dosage and simple cloning protocols, then ease of manufacture is improved, but metabolic burden increases and productivity decreases
Solution Approach 1:
The invention extracts the gene of interest from the plasmid context and integrates it directly into the bacterial chromosome. This removes the plasmid replication machinery and associated metabolic burden while maintaining the gene's expression capability through chromosomal integration at suitable loci with appropriate promoters.
Solution Approach 2:
The invention merges the gene of interest with the bacterial chromosomal DNA through site-specific recombination. This integration combines the advantages of chromosomal stability with controlled expression, eliminating the need for separate plasmid maintenance while ensuring consistent inheritance during cell division.
2Quantity of substance
If plasmid-based systems are used to achieve high gene dosage, then expression potential is improved, but segregational and structural instability increase
Solution Approach 1:
The invention extracts the gene from the unstable plasmid context and relocates it to the stable chromosomal environment. This transfer eliminates segregational instability (loss of plasmid during cell division) and structural instability (plasmid mutations) while maintaining the gene's functional integrity.
Solution Approach 2:
Instead of increasing plasmid copy number to achieve high gene dosage, the invention inverts the approach by integrating the gene into the chromosome where single-copy or low-copy integration provides stable inheritance. The expression level is controlled through promoter strength and integration site selection rather than copy number amplification.
3Productivity
If strong promoters are used in combination with high gene dosage to increase expression rate, then productivity is improved, but host cell metabolism breaks down
Solution Approach 1:
The invention changes the fundamental parameter of gene dosage from high (plasmid copy numbers) to low (chromosomal integration), and compensates by optimizing promoter strength and integration site. This parameter change allows sustained expression without metabolic collapse, as the chromosomal location provides stable inheritance and the promoter can be tuned to appropriate expression levels.
Solution Approach 2:
The invention introduces dynamic control of expression through inducible promoters (e.g., T7 lac promoter systems) that allow the host cell to maintain normal metabolism during growth phase and then induce high-level expression when needed. This dynamic regulation prevents metabolic breakdown by separating growth phase from production phase.
4Productivity
If plasmid-based systems are used to achieve high expression rates, then productivity is improved, but process controllability decreases
Solution Approach 1:
The invention implements feedback control through inducible promoter systems (e.g., T7 lac promoter with IPTG induction) where expression is tightly controlled by external signals. This allows precise temporal control of protein production, enabling the process to be paused during growth and activated when optimal conditions are reached, thereby improving overall process controllability.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A method for producing a protein of interest on a manufacturing scale is based on integration, by homologous recombination, of the DNA encoding the protein of interest into a bacterial cell's genome at a pre-selected site. The manufacturing scale production of recombinant proteins is in the fed-batch mode, semi-continuous or in a chemostat.